Evan Shlofmitz

[Davide Capodanno @DFCapodanno]

This year, TCT is stopping in San Diego (and I’ll have to take three flights to get there), and the late-breaking lineup is quite interesting. Here are my favourites, both journalistically and from an interventional cardiology perspective:

1/ P4, a trial of CCTA-guided vs IVUS-guided PCI. We published the design paper in EuroIntervention. Check it out: https://t.co/AKquRrPmKW

2/ TRANSFORM II, or DCB strategy vs DES, Act III. With REC-CAGEFREE I coming out negative and SELUTION DeNovo being so-so, we really needed a tiebreaker. And here it is.

3/ HD-PCI, a randomized trial of higher vs lower-dose heparin for PCI. I like trials that answer practical, “in or out” questions. I also have to discuss this one right after the presentation, so I’m studying it carefully.

4/ PROGRESS: TAVR or clinical surveillance for moderate aortic stenosis. I still haven’t quite figured out the ambition and magnitude of these TAVR trials in moderate AS. The first one, TAVR UNLOAD, didn’t leave much of a mark. We don’t know when EXPAND TAVR II will be presented, but I suspect it’ll be soon. And then there’s PROGRESS, the largest of them all in terms of patient numbers. By the way, https://t.co/eTrBhHpXH5 says follow-up will end in 2037. As we say back home, campa cavallo.

5/ SIMPLAAFY, antithrombotic monotherapy after left atrial appendage occlusion. I like this trial if only for its name, and I can’t wait to hear how people pronounce it. More importantly, it could give DAPT a serious shove out the door, since it seems to be the main burden holding back LAAO at the moment.

6/ PIONEER IV, angiography-derived FFR vs usual care for lesion selection and optimization in all-comers PCI. Another QFR trial occupying an intermediate position on the physiology spectrum between FAVOR III Europe and FAVOR III China.

7/ VERONICA, where researchers are trying to demonstrate the usefulness of platelet-function testing to identify patients with excessive platelet inhibition (usually, it’s the opposite) and see whether a de-escalation strategy could reduce the combined risk of ischemic and bleeding events.

[BostonSci Cardiology @BSCCardiology]

This just in – ONPATH™ Software for the AVVIGO™+ Multi-Modality Guidance System has received FDA 510(k) clearance! 🎉

ONPATH software expands your smart toolset with high-definition IVUS imaging and AI-powered analysis, helping you focus on what matters most. Learn more: https://t.co/nnD4xa92QR

AVVIGO™+ Multi-Modality Guidance System with ONPATH™ Software indications, safety, and warnings: https://t.co/Ee8kPFbUOU

[OPCI @OPCILive]

📢Calling All Fellows! The deadline to submit a complex PCI case is approaching next Friday, October 30. ⌛️Selected cases will be presented and the presenting fellow will earn an expenses-paid faculty position. Don't miss out!

OPCI Detroit Clinical Mastery Summit | November 21 🗓️ Tackle the toughest decisions in contemporary coronary intervention through expert lectures, case-based discussion, debate, and hands-on simulation.

👉Register Now and Submit Your Case: https://t.co/VeptFjzNZR

@ESHLOF @ziadalinyc @DrAllenJ @DrAmirKaki
@d_sukul @RyanMadderMD @CanteyEric

[J&J MedTech | Circulatory Restoration @JJMT_CircRest]

First impressions are in. ✈️ Shout out to the operators and cath lab teams who were among the first to perform #ShockwaveC2AeroFly commercial cases and experience the benefits of 2x faster pulsing.

Drs. Ziad Ali (@ziadalinyc), Rich Shlofmitz, Evan Shlofmitz (@ESHLOF), Paul Sapia (@PaulSap9), Allen Jeremias (@DrAllenJ), Annapoorna Kini (@DoctorKini), Samin Sharma, Amit Hooda (@AmithoodaMD), Prashant Kaul (@KaulP), Hector Tamez (@hectortamezmd), Robert Stoler, Subhash Banerjee, Chadi Dib, Karim Al-Azizi (@kalazizimd), Emmanouil Brilakis (@esbrilakis), and Yousif Ahmad

Treatment time includes pulsing time and pause time. Pause time may vary by patient need. US Rx only. Safety Info: https://t.co/as4irbY3DX
Product availability may vary by country.

[OPCI @OPCILive]

Detroit Complex PCI Summit: Tackle Tough Cases, Hands-On! Nov 21 | Register Now 👉https://t.co/vhzi6lLXRD

Sharpen your clinical decision-making through expert lectures, case-based discussion, debate, and hands-on simulation. Open to interventional cardiologists, fellows, nurses, and cath lab technologists.

Special Incentive for Fellows:

🏨✈️Complimentary travel and housing is available to fellows attending the Summit, thanks to a travel grant from the Shlofmitz Heart Foundation. Terms and conditions apply.

📢Submit a complex PCI case when you register. Selected cases will be presented at the Summit, and each presenting fellow will receive a faculty position with all expenses paid.

@ESHLOF @ziadalinyc @DrAllenJ @DrAmirKaki @d_sukul @RyanMadderMD @CanteyEric

[Roosha Parikh @rooshaparikh]

Proud to see our work featured in a new meta-analysis in #JACCImaging!

Even more rewarding to see TWO studies I contributed to- Parikh R et al. and Sakai K et al. included in the central illustration and evidence supporting photon-counting CT from our work

These findings highlight how advances in CT technology may influence not only image quality and diagnostic confidence, but also downstream patient management.

Grateful to my colleagues and collaborators at @StFrancis_LI for their continued dedication to advancing cardiovascular imaging research.
@OKhaliqueMD @DoosupShin @ziadalinyc @ESHLOF

Exciting times for #PCDCT #yesCCT #jaccimaging! 🚀

https://t.co/YRlkFUGEmV

[OPCI @OPCILive]

Watch OPCI Live |Welcome to the Limus Era: SELUTION in ISR. Case operators Dr. Richard Shlofmitz and @DrAllenJ. Moderators @djc795 @AlokeFinn @DBliagos @ESHLOF @DoosupShin.

https://t.co/eHvf7ngM3H

[Rick Volleberg @RickVolleberg]

This one took countless hours of many people!

AI-based OCT image analysis tested against expert interobserver agreement in a large-scale consecutive real-world dataset.

🚨🚨 Consistent performance supporting generalizability!

https://t.co/9PHRSTrygV

@ziadalinyc @NielsRoyen

[Gregg W. Stone MD @GreggWStone]

1/2 Our updated meta-analysis of intravascular imaging guidance publ in JACC. Since our last synthesis in Lancet 2024, there have been 6 new RCTs with 8,670 additional pts. Total is now 28 RCTs with 24,634 patients with mean FU 22 mos. Should be enough for a definitive answer!

[PCRonline 🫀 @PCRonline]

International Day for Interventional Cardiology: the first coronary #angioplasty

On 16 September 1977, Andreas Grüntzig & his team made history, and changed the lives of millions of patients forever.

Standing on the shoulders of the giants that came before him, this transformative vision led to an entirely new field of medicine.

What began nearly five decades ago with coronary angioplasty has grown into the broad field of interventional cardiology, transforming cardiovascular care through research, innovation and technological progress.

As the field has evolved, so has the need to learn from experience, share knowledge and shape what comes next. Join us in 2027 at #EuroPCR to mark this landmark moment!

📅https://t.co/OPA8J77TJ0

#medicalhistory #interventionalcardiologist #cathlab #cathlabteam

@NievesGonzalo1 @CuissetDr @nicolasdumonte1 @EmanueleBarba13

[Giorgio A. Medranda MD, FACC, FAHA, FSCAI @GiorgioMedranda]

Calling interventional cardiology fellows! 🚨

The #OPCI #Nashville Summit brings together interventional cardiologists, fellows, nurses & imaging techs!

Submit a complex #PCI case at registration—selected fellows will present their case and earn a fully funded faculty position!

[OPCI @OPCILive]

Watch OPCI Journal Club: Determining the Physiological Threshold for Angina (ORBITA-FIRE): A Double-Blind, Randomized, Placebo-Controlled Study with Drs. Fiyyaz Ahmed & @rallamee. Along with panelists @DFCapodanno @djc795 @ziadalinyc @DrAllenJ @JEscaned @JWMoses.

https://t.co/ulDWDIUXVx

[Jaffar Khan @CathElectroSurg]

🫀 Structural Heart Fellowship — St. Francis Hospital

Combined clinical + research. One of the highest case volumes in the world. Hands-on electrosurgery training. Open to US and international applicants completing IC training.

Interviews in September. DM me.

[Carlos Collet MD PhD @ColletCarlos]

What began as an idea #CTguidedPCI is becoming an increasingly accessible platform for interventional cardiologists.

Today, at least four companies—@HeartFlow, @Cleerly, @ElucidBio, and @SiemensHealth —have developed dedicated #CCTA platforms for the interventional cardiologist 👇

Now the field is waiting for the pivotal #P4 trial, to be presented at @TCTMD.

The next chapter of PCI planning is about to begin 💪

#CTguidedPCI #Cardiology #TCT2026 @crfheart @PCRonline

[OPCI @OPCILive]

Watch today's OPCI Journal Club "The Future of Medical Publishing" featuring @DFCapodanno.

Panelists @djc795 @ziadalinyc @JEscaned @DoosupShin.

👉https://t.co/Y6otl0DpsZ

[RAMPART @RAMPARTic]

The new standard in radiation safety has arrived—and Rampart is helping lead the way.

Following the landmark six-society consensus, we’ve launched https://t.co/FcQM3Dnb4W—a comprehensive resource library featuring consensus summaries, ALARA education, clinical evidence, ERPD evaluation guides, FAQs, and more.

🔗 https://t.co/FcQM3Dnb4W

#RadiationSafety #ERPD #LeadFreeERPD #ALARA #ShedTheLead

[OPCI @OPCILive]

Register Now! OPCI Nashville Clinical Mastery Summit: Complex Coronary Interventions. 📆September 26, Virgin Hotels Nashville🎸🎶

https://t.co/WlZ99YD48h

Join OPCI for an intensive, single-day advanced interventional cardiology program designed to sharpen clinical decision-making through case-based learning and hands-on simulation. 🙋

📢Special Incentives for Fellows:

✔️Travel Voucher: If you are traveling more than 2 hours to reach the Summit, you will receive a $300 travel voucher following the event.
✔️Call for Cases: Submit a complex PCI case upon registration. Selected cases will be presented at the Summit, and the presenting fellow will be awarded a faculty position, with all expenses paid.

@ziadalinyc @ESHLOF @DrAllenJ @kerrigjl @nadia_sutton #cardiox #InterventionalCardiology #CardioEd

[OPCI @OPCILive]

Watch the latest OPCI Journal Club: Angiography-Derived Fractional Flow Reserve to Guide PCI featuring Dr. Ajay Kirtane. Panelists @djc795 @ziadalinyc @ESHLOF @PaulSap9 @DoosupShin.

https://t.co/FcbPFEG57v

[Yader Sandoval @yadersandoval]

Intracoronary imaging continues to evolve rapidly.

Now online in @AmJCardio: our comprehensive review, led by Dr. Jas Sara, covers the evidence supporting IVUS- and OCT-guided PCI, practical procedural guidance, and emerging innovations including AI, angiographic co-registration, image-derived physiology, and novel imaging platforms.

📄 https://t.co/zRWi1ket9L

@CCAD_MHIF @PedroEPCarvalho @arnoldseto @ESHLOF @esbrilakis @DStrepkos @m1chaella_alex

[MyJSCAI @MyJSCAI]

📣NEW @SCAI Document: Enhanced #radiationprotection should no longer be optional. This consensus defines the ethical & legal duty across governments, manufacturers, & health care institutions to reduce preventable #occupationalrisk. Read in #JSCAI today:

➡️https://t.co/HNXVvIevJz

@RizikMd @nadia_sutton @AlexandraLansky @mirvatalasnag @MCoylewright @AGoldsweig @djkereiakes @RyanMadderMD @Drroxmehran @wjn_md @SVRaoMD @KTamirisaMD @Pooh_Velagapudi @anvoramd @CelinaMYongMD @Herms2James